6618 — JD Health International Share Price
0.000.00%
Last trade - 00:00- HK$72.87bn
- HK$29.31bn
- CNY53.53bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.44 | ||
| PEG Ratio (f) | 0.42 | ||
| EPS Growth (f) | 58.38% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.36 | ||
| Price to Tang. Book | 1.43 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.26 | ||
| EV to EBITDA | 24.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.8% | ||
| Return on Equity | 4.55% | ||
| Operating Margin | 1.67% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 10,842.14 | 19,382.57 | 30,682.27 | 46,736.15 | 53,529.94 | 62,169.83 | 72,897.78 | 45.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +460.01 | +90.61 | +19.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.
Directors
- Qiangdong Liu NEC (48)
- Enlin Jin CEO (41)
- Dong Cao CFO (44)
- Ming King Chiu SEC (44)
- Lijun Xin NED (47)
- Lei Xu NED (46)
- Ran Xu NED (44)
- Qingqing Yi NED (49)
- Xingyao Chen NID (46)
- Zhang Jiyu NID (39)
- Ling Li NID (59)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 30th, 2018
- Public Since
- December 8th, 2020
- No. of Employees
- 3,118
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 3,189,115,111
- Address
- 8th Floor, Building C No. 18 Kechuang 11, BEIJING, 101111
- Web
- https://ir.jdhealth.com/
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 6618
Half Year 2024 JD Health International Inc Earnings Release
Similar to 6618
Alibaba Health Information Technology
Stock Exchange of Hong Kong Limited
Alpha Professional Holdings
Stock Exchange of Hong Kong Limited
Asia Grocery Distribution
Stock Exchange of Hong Kong Limited
Best Mart 360 Holdings
Stock Exchange of Hong Kong Limited
Beijing Properties (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
What is the JD Health International share price?
As of Today at 19:12 UTC, shares in JD Health International are trading at HK$22.85. This share price information is delayed by 15 minutes.
How has the JD Health International share price performed this year?
Shares in JD Health International last closed at HK$22.85 and the price had moved by -59.91% over the past 365 days. In terms of relative price strength the JD Health International share price has underperformed the FTSE Developed Asia Pacific Index by -58.16% over the past year.
What are the analyst and broker recommendations for JD Health International?
The overall consensus recommendation for JD Health International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the JD Health International dividend yield?
JD Health International does not currently pay a dividend.
Does JD Health International pay a dividend?
JD Health International does not currently pay a dividend.
When does JD Health International next pay dividends?
JD Health International does not currently pay a dividend.
How do I buy JD Health International shares?
To buy shares in JD Health International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of JD Health International?
As of the previous close price of HK$22.85, shares in JD Health International had a market capitalisation of HK$72.87bn.
Where are JD Health International shares listed?
Here are the trading details for JD Health International:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6618
What kind of share is JD Health International?
Based on an overall assessment of its quality, value and momentum JD Health International is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a JD Health International share price forecast for 2024?
The analyst consensus target price for shares in JD Health International is HK$43.27. That is 89.35% above the last closing price of HK$22.85.
Analysts covering JD Health International currently have a consensus Earnings Per Share (EPS) forecast of CNY1.29 for the next financial year.
What is the trend in the JD Health International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like JD Health International. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -40.65%.
As of the last closing price of HK$22.85, shares in JD Health International were trading -39.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the JD Health International PE Ratio?
The JD Health International PE ratio based on its reported earnings over the past 12 months is 15.44. The shares last closed at HK$22.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of JD Health International?
JD Health International's management team is headed by:
- Qiangdong Liu - NEC
- Enlin Jin - CEO
- Dong Cao - CFO
- Ming King Chiu - SEC
- Lijun Xin - NED
- Lei Xu - NED
- Ran Xu - NED
- Qingqing Yi - NED
- Xingyao Chen - NID
- Zhang Jiyu - NID
- Ling Li - NID